
When using a therapy to clear the senescent cells, disease progression and cell death were stopped, according to the study.

When using a therapy to clear the senescent cells, disease progression and cell death were stopped, according to the study.

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.

The existing EUA was also amended to reduce the time for booster dose administration from a minimum of 6 months to at least 5 months following completion of the primary COVID-19 vaccine series.

Pharmacists can play a key role in providing education and guidance to patients with glaucoma.

The Breakthrough Therapy Designation was granted based on data from the dose escalation portion of 2 expansion cohorts of a 3-cohort phase 1 study.

Results from a study conducted by the Institute for Health Metrics and Evaluation show that new cases jumped 26.3% over the same period.

Study results show that these regimens increased the chances of treatment success among individuals aged 3 to 18 years compared to standard therapeutics.

Witch hazel is used for conditions such as diarrhea, mucus colitis, and various other skin irritations.

Rivaroxaban is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the treatment of deep vein thrombosis, and pulmonary embolism.

Small GISTs may cause no symptoms and may grow so slowly that they have no serious effects.

The FDA has granted emergency use authorization for a COVID-19 at-home test (Roche) and a rapid COVID-19 antigen self-test (Clinitest; Siemens Healthineers).

Individuals receiving the therapy had an 87% reduction in risk for the composite primary endpoint of virus-related hospitalization or all-cause death by day 28.

The therapeutic is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022.

When assessing treatments for flu and cold symptoms, it is important for the pharmacist to consider not only the patient’s current medication regimen, but also other OTCs and disease states.

The approval is based on efficacy and safety data from 2 positive phase 3 studies that evaluated a combined study population of 166 individuals, which represented the US population with Cushing syndrome.

The research team compared the monthly average blood pressures between 2018 and 2019 with blood pressure measures from January through March 2019 to January through March 2020.

Staffing shortage hits technician ranks hardest, putting additional pressure on pharmacists.

The research team looked at a pooled analysis of all published studies to re-evaluate the relationship between regular exercise and the risk of developing pneumonia.

The findings showed that people with HIV were 68% more likely to develop heart failure than people who did not have HIV.

Anxiety disorders and depression were cited by more than 80% of oncologists as the types of mental health distress seen most often for patients.

The study authors sought to determine the proportion of states that elected to follow CDC recommendations by identifying each state’s COVID-19 vaccination webpage through keyword-based internet search and set out to identify information about vaccinations for patients with cancer.

Immune B cells secrete immunoglobin A antibodies that work on mucosal surfaces in the nose, stomach, and lungs.

Curoxen helps to prevent infection and treats cuts, scrapes, blisters, and burns.

Advair Diskus is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease.

Symptoms of Gaucher disease include abdominal complaints, skeletal abnormalities, and blood disorders.

A lack of access, awareness, and trust have led to a lack of affordability, effectiveness, and inclusivity.

Avapro (Irbesartan) is indicated for the treatment of hypertension and used to lower blood pressure.

OTC case studies for December 2021.

Melanoma is responsible for 80% of skin cancer deaths.

The FDA approves anifrolumab-fnia injection (Saphnelo; AstraZeneca) for the treatment of adults with moderate to severe system- ic lupus erythematosus (SLE) who are receiving standard therapy.